Sativex sublingual cannabis extract spray: Completed Phase II/III enrollment

GW completed enrollment of 360 patients in a single and double-blind, placebo-controlled, dose-escalation, international Phase II/III trial evaluating Sativex. Bayer has rights to market Sativex in Ca...